<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04948957</url>
  </required_header>
  <id_info>
    <org_study_id>2013-81-03/09</org_study_id>
    <nct_id>NCT04948957</nct_id>
  </id_info>
  <brief_title>Changes in Cerebral Oxygenation and Cognitive Functions</brief_title>
  <official_title>Changes in Cerebral Oxygenation and Cognitive Functions During Controlled Hypotension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zonguldak Bulent Ecevit University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zonguldak Bulent Ecevit University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study aimed to assess the influence of nitroglycerin and esmolol-induced&#xD;
      hypotension on cerebral oxygen saturation by using near-infrared spectroscopy and&#xD;
      postoperative cognitive function in patients undergoing nasal surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2014</start_date>
  <completion_date type="Actual">August 1, 2016</completion_date>
  <primary_completion_date type="Actual">January 1, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>effects of controlled hypotension on cerebral oxygen saturation</measure>
    <time_frame>until end of the surgical procedure.</time_frame>
    <description>influence of nitroglycerin and esmolol-induced hypotension on cerebral oxygen saturation by measuring regional cerebral oxygen saturation using Near-Infrared Spectroscopy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>effects of controlled hypotension on cognitive function</measure>
    <time_frame>24 hour before surgery and 24 hour after surgery</time_frame>
    <description>influence of nitroglycerin and esmolol-induced hypotension on postoperative cognitive function using mini mental test score</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">40</enrollment>
  <condition>Hypotension; Controlled</condition>
  <condition>Cognitive Dysfunction</condition>
  <arm_group>
    <arm_group_label>esmolol (Group E)</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>nitroglycerin (Group N)</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Esmolol</intervention_name>
    <arm_group_label>esmolol (Group E)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nitroglycerin</intervention_name>
    <arm_group_label>nitroglycerin (Group N)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        - required controlled hypotension scheduled for nasal surgeries&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  written informed consent&#xD;
&#xD;
          -  patients with ASA physical status of I-II&#xD;
&#xD;
          -  aged 18-65 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age under 18 or above 65&#xD;
&#xD;
          -  ASA &gt; II&#xD;
&#xD;
          -  coagulation disorders&#xD;
&#xD;
          -  history of cardiovascular and cerebrovascular disease&#xD;
&#xD;
          -  poor Blood Pressure control&#xD;
&#xD;
          -  anemia, pregnancy, addiction to opioids&#xD;
&#xD;
          -  body mass index (BMI) &gt; 35&#xD;
&#xD;
          -  intraoperative systolic BP &lt; 65 mmHg&#xD;
&#xD;
          -  surgical duration less than 30 minutes or more than 160 minutes&#xD;
&#xD;
          -  need for an intraoperative sympathomimetic drug and the use of other hypotensive drugs&#xD;
&#xD;
          -  preoperative Mini-Mental State Examination (MMSE) score of 23 or less.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Zonguldak Bülent Ecevit University Medicine Faculty</name>
      <address>
        <city>Zonguldak</city>
        <state>Kozlu</state>
        <zip>67600</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 12, 2021</study_first_submitted>
  <study_first_submitted_qc>June 22, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 2, 2021</study_first_posted>
  <last_update_submitted>June 22, 2021</last_update_submitted>
  <last_update_submitted_qc>June 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zonguldak Bulent Ecevit University</investigator_affiliation>
    <investigator_full_name>Bengü Gülhan Aydin</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>cerebral oxygenation</keyword>
  <keyword>cognitive function</keyword>
  <keyword>esmolol</keyword>
  <keyword>nitroglycerine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nitroglycerin</mesh_term>
    <mesh_term>Esmolol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

